Are diabetes management guidelines applicable in 'real life'?

Diabetology and Metabolic Syndrome

Volumn 4, Issue 1, 2012, Pages

  Viana, Luciana V ^a   Leitão, Cristiane B ^a   Grillo, Maria De Fátima ^a   Rocha, Ennio P C C ^a   Brenner, Juliana K ^a   Friedman, Rogério ^a   Gross, Jorge L ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

ADA guidelines; Real life; Type 2 diabetes

Indexed keywords

GLIBENCLAMIDE; HEMOGLOBIN; HEMOGLOBIN A1C; ISOPHANE INSULIN; METFORMIN;

ADULT; AGED; ARTICLE; BRAZIL; COMORBIDITY; CONTROLLED STUDY; DISEASE DURATION; FEASIBILITY STUDY; FEMALE; FUNDING; HEALTH CARE SYSTEM; HUMAN; HYPERTENSION; HYPOGLYCEMIA; INSULIN TREATMENT; INTERVENTION STUDY; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRACTICE GUIDELINE; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE;

EID: 84869235840     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-4-47     Document Type: Article

References (16)

1. Management of Hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. Nathan DM, Buse JB, Davison MB, Heine RJ, Holman RR, Sherwin R, Zinman B, Diabetes Care 2006 49 1963 1972
2. Management of Hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B, Diabetes Care 2009 32 193 203 10.2337/dc08-9025 18945920
3. Evaluation of tests of microalbuminuria screening for patients with diabetes. Incerti J, Zelmanovitz T, Camargo JL, Gross JL, Azevedo MJ, Nephrol Dial Transplant 2005 20 2402 2407 10.1093/ndt/gfi074 16105865 (Pubitemid 41548863)
4. Glycemic Control with Diet, Sulfonylurea, Metformin, or Insulin in Patients with Type 2 Diabetes: Progressive Requirement for Multiple Therapies (UKPDS 49). Turner RC, Cull CA, Frighi V, Holman RR, JAMA 1999 21 2005 2012 (Pubitemid 29254858)
5. Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy. Kahn SE, Haffner SM, Heise MA, Herman WH, Holman RR, Jones NP, et al. N Eng J Med 2006 23 2427 2443 (Pubitemid 44903747)
6. The treat-to-target trial: Randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Riddle MC, Rosenstock J, Gerich J, Diabetes Care 2003 26 3080 3086 10.2337/diacare.26.11.3080 14578243 (Pubitemid 37339502)
7. Patient adherence to medication requirements for therapy of type 2 diabetes. Bailey CJ, Kodack M, Int J Clin Pract 2011 65 314 322 10.1111/j.1742-1241.2010.02544.x 21314869
8. Prevalence and correlates of inadequate glycemic control: results from nationwide survey in 6,671 adults with diabetes in Brazil. Mendes ABV, Fittipaldi JAS, Neves RCS, Chacra AR, Moreira-Jr ED, Acta Diabetol 2010 47 137 145 10.1007/s00592-009-0138-z 19655083
9. Viana LV, Tese de Doutorado: Controle Glicêmico de Pacientes com Diabetes Tipo 2 nas Cinco Regiões do Brasil e Análise de efetividade de um programa de controle da glicemia E da hipertensão arterial sistêmica na rede pública Porto Alegre, Brazil: Universidade Federal do Rio Grande do Sul 2012
10. Contributions of fasting and post-prandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients. Monnier L, Lapinski H, Collete C, Diabetes Care 2003 26 881 885 10.2337/diacare.26.3.881 12610053 (Pubitemid 36929359)
11. The Effect of Oral Antidiabetic Agents on A1c Levels. Sherifali D, Nerenberg K, Pullenayegum E, Cheng JE, Gerstein HC, Diabetes Care 2010 8 1859 1864
12. Improving glycemic control of patient with type 2 diabetes in primary care setting: a French application of the Staged Diabetes Management programme. Varroud-Vial M, Simon D, Attali J, Durand-Zaleski I, Bera L, Attali C, et al. Diabet Med 2004 21 592 598 10.1111/j.1464-5491.2004.01207.x 15154945 (Pubitemid 38746280)
13. Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Diabetes Care 2012 35 6 1364 1379 10.2337/dc12-0413 22517736
14. Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study. Currie CJ, Peters JR, Tynan A, Evans M, Heine RJ, Bracco OL, et al. Lancet 2010 375 9713 481 489 10.1016/S0140-6736(09)61969-3 20110121
15. Megatrials in type 2 diabetes. From excitement to frustration? Del Prato S, Diabetologia 2009 52 7 1219 1226 10.1007/s00125-009-1352-5 19373446
16. Nutritional intervention in patients with type 2 diabetes who are hyperglycemic despite optimized drug treatment-Lifestyle Over and Above Drugs in Diabetes (LOADD) study: randomized controlled trial. Coppell KJ, Katoaka M, Williams SM, Chisholm AW, Vorgers SM, Mann JI, BMJ 2010 341 3337 10.1136/bmj.c3337 20647285